Skip to content
Welcome to Heart Matters - Empowering Heart Health

Terms of use

Terms of Service
Last updated: June 13, 2025

1. Acceptance of Terms
By accessing and using the Heart Matters website ("the Website"), you agree to be bound by these Terms of Service. We may update these terms at any time. Continued use of the Website signifies your acceptance of any changes.

2. Use of Information
All content on this Website is provided for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider regarding any medical concerns or conditions.

3. Educational Resources
The Website offers general information related to heart health and related topics. This content is not intended to replace professional care or create a doctor-patient relationship. Please seek advice from a qualified health professional before making health-related decisions.

4. No Medical Advice
Heart Matters does not offer personalised medical advice or clinical services. Use of the Website does not establish a provider-patient relationship.

5. Email Communications
By subscribing to our newsletter, you agree to receive periodic emails related to heart health and Website updates. You may unsubscribe at any time via the link provided in each email.

6. Intellectual Property
All content on the Website—including text, images, graphics, logos, and videos—is the property of Heart Matters and protected by intellectual property laws. Reproduction or distribution without written consent is prohibited. For permissions, contact: info@heartmatters.com.

7. Limitation of Liability
Heart Matters makes no warranties regarding the accuracy or reliability of the Website’s content. Use of the Website is at your own risk. We are not responsible for any loss or damage resulting from your reliance on the Website.

8. Third-Party Links
The Website may contain links to external websites. These are provided for convenience only. Heart Matters does not endorse and is not responsible for their content or privacy practices.

9. Modification of Terms
We reserve the right to modify these Terms of Service without prior notice. Your continued use of the Website constitutes agreement to the revised terms.

10. Confidentiality and Privacy
Our use of data is governed by our Privacy Policy. While we strive to protect your data, communications via the internet are not fully secure. Please avoid sending confidential or proprietary information through the Website.

11. Accuracy and Completeness
While we aim to provide accurate and current information, the content on this site is provided "as is" without any express or implied warranties. You are encouraged to verify health information through trusted sources.

Neither Heart Matters, Professor Peter Barlis, nor any contributing authors are liable for errors, omissions, or outcomes related to the use of this information.

Author

  • Heart Matters, edited by cardiologist Professor Peter Barlis, is a trusted resource that offers clear and accurate information on cardiovascular health. It bridges the gap between scientific research and everyday understanding, empowering you to make informed choices and take an active role in supporting your heart health.

informing hearts
empowering lives

Subscribe to our newsletter and be the first to receive valuable insights, tips, and resources on heart health.

other anti-anginals

When first-line therapies for angina, such as beta blockers, calcium channel blockers, and nitrates, prove inadequate or are not well-tolerated, second-line therapies may be considered.
Perhexiline is a unique medication that enhances the heart's ability to utilize fatty acids for energy, reducing its reliance on oxygen and lowering oxygen demand. This action helps improve blood flow and alleviates chest pain in some patients with refractory angina.
Nicorandil is another second-line option with a dual mechanism of action. It opens potassium channels in smooth muscle cells, causing vasodilation and enhancing coronary blood flow. Additionally, nicorandil also stimulates nitric oxide release, further dilating blood vessels and reducing heart workload.
Trimetazidine is an anti-ischemic agent that improves cardiac efficiency by enhancing glucose metabolism and shifting the heart's energy production to a more oxygen-efficient process. As second-line therapies, these medications offer alternative approaches for managing angina in individuals who do not respond adequately to first-line treatments or those experiencing side effects from other medications.

lipid lowering therapies

Lipid-lowering therapies play a critical role in managing coronary artery disease (CAD), a condition characterized by the narrowing of blood vessels that supply the heart. Among the most commonly discussed and debated classes of medications are statins, which effectively reduce cholesterol levels and are widely prescribed to lower the risk of cardiovascular events. Alongside statins, other medications like ezetimibe, fibrates, and niacin are also utilized to target specific aspects of lipid metabolism, such as cholesterol absorption, triglyceride levels, and raising high-density lipoprotein (HDL) cholesterol. Additionally, the introduction of medications that inhibit PCSK9, an enzyme involved in cholesterol metabolism, has provided a promising new approach to further lower LDL cholesterol levels. These PCSK9 inhibitors, such as Repatha (evolocumab), have shown significant efficacy in reducing LDL cholesterol levels in patients with CAD, especially for those who may not respond well to traditional therapies.

Nitrates

Nitrates are widely used to treat angina and provide quick relief for chest pain. Commonly available in the form of sublingual sprays or tablets, patches, and long-acting tablets, nitrates work by dilating blood vessels, allowing for increased blood flow and reduced resistance. This dilation eases the heart's workload, leading to a decreased demand for oxygen and prompt alleviation of angina symptoms. Sublingual nitrates act rapidly and are often used to provide immediate relief during angina attacks, while patches and long-acting tablets are employed for preventive purposes. However, nitrates may cause side effects such as headaches, dizziness, and flushing, which usually subside over time.

calcium channel blockers

Calcium channel blockers, including amlodipine, felodipine, cardizem (diltiazem), and verapamil, are commonly prescribed for the treatment of angina. These medications work by inhibiting the influx of calcium into the muscle cells of the heart and blood vessels, leading to their relaxation. As a result, blood vessels widen, promoting improved blood flow and reduced blood pressure. In the context of angina, this relaxation decreases the heart's workload, lowering the demand for oxygen and alleviating chest pain. Calcium channel blockers offer a valuable treatment option for individuals with angina, but it is essential to be aware of potential side effects, which may include headaches, dizziness, flushing, and ankle swelling.

Beta blockers

Beta blockers, such as metoprolol, propranolol, atenolol, carvedilol, and bisoprolol, play a crucial role in treating angina. By blocking certain receptors in the heart, they effectively reduce heart rate and the force of contraction, thereby easing the heart's workload. This mechanism of action leads to a decreased demand for oxygen, making beta blockers highly effective in relieving chest pain associated with angina. As with any medication, it's important to consider potential side effects, including tiredness, worsened asthma, erectile dysfunction in some males, and more vivid dreams during sleep. Consult your healthcare provider to determine the suitability of beta blockers for managing your angina and overall heart health.

Anti-platelet Medications

Anti-platelet medications play a crucial role in preventing blood clot formation, reducing the risk of serious cardiovascular events such as heart attacks and strokes. Among the widely used anti-platelet drugs are aspirin, clopidogrel, and ticagrelor.

Aspirin: This well-known medication inhibits platelet activation, making it less likely for platelets to stick together and form clots. Aspirin is commonly used for primary and secondary prevention of heart attacks and strokes.

Clopidogrel: As a potent anti-platelet agent, clopidogrel works by blocking specific receptors on platelets, preventing them from aggregating. It is often prescribed to patients with acute coronary syndrome, those undergoing stent procedures, and for some cases of peripheral arterial disease.

Ticagrelor: Ticagrelor is another effective anti-platelet drug that works by inhibiting platelet activation. It is used in acute coronary syndrome, often given alongside aspirin to reduce the risk of heart-related events.